Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0X1YF
|
||||
Former ID |
DIB010794
|
||||
Drug Name |
T-1095
|
||||
Synonyms |
RWJ-394718; T-0687; T-1095A; SGLT-2 inhibitors (diabetes), Tanabe/Johnson & Johnson
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Diabetes [ICD9: 253.5, 588.1; ICD10:E23.2, N25.1] | Discontinued in Phase 2 | [546954] | ||
Company |
Tanabe Seiyaku Co Ltd
|
||||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C26H28O11
|
||||
Canonical SMILES |
[C@@H]1([C@@H]([C@H]([C@@H]([C@H](O1)COC(=O)OC)O)O)O)Oc<br />1c(c(cc(c1)C)O)C(=O)CCc1cc2c(occ2)cc1
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Sodium/glucose cotransporter 1 | Target Info | Modulator | [525583] | |
PathWhiz Pathway | Lactose Degradation | ||||
Trehalose Degradation | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.